Pfizer agrees to license generic versions of its COVID-19 pill — in some countries

pfizer agrees to license generic versions of its covid 19 pill in some countries

Sumary of Pfizer agrees to license generic versions of its COVID-19 pill — in some countries:

  • In late summer, protesters at Pfizer’s world headquarters in New York urged the drugmaker to broadly share the patent for its COVID-19 vaccine.
  • Bruce Gilbert/AP hide caption toggle caption Bruce Gilbert/AP Pfizer’s agreement with a U.N.
  • In late summer, protesters at Pfizer’s world headquarters in New York urged the drugmaker to broadly share the patent for its COVID-19 vaccine.
  • Bruce Gilbert/AP Pfizer has signed a licensing deal to allow dozens of lower-income countries to benefit from generic versions of its new COVID-19 pill.
  • -backed Medicines Patent Pool organization, said in a joint news release with Pfizer.
  • The licensing deal applies to 95 countries, covering up to approximately 53% of the world’s population, according to Pfizer and the MPP.

Want to know more click here go to source.

From -

Close

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close